BALAJI AMINES LTD.-$
P&L
Quarterly Consolidated
vs Q2 FY26
Balaji Amines Q3FY26 Revenue at ₹ 336 Crore, EBITDA at ₹ 62 Crore, Net Profit at ₹ 31 Crore
30 Jan 2026 · 30 Jan, 12:48 pm
Summary
Balaji Amines Limited, a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, announced its unaudited financial results for the quarter ended December 31, 2025. The company reported a consolidated revenue of ₹ 336 crore, an EBITDA of ₹ 62 crore, and a net profit of ₹ 31 crore for Q3FY26.
Key Highlights
- 1
Revenue from Operations for Q3FY26 stood at ₹ 331.30 crore
- 2
Total volumes stood at 25,894.09 MT for Q3 FY26 as against 24,097.44 MT in Q3 FY25
- 3
EBITDA for Q3FY26 was ₹ 61.67 crore
- 4
PAT for Q3FY26 was ₹ 30.76 crore
- 5
Diluted EPS for Q3FY26 stood at ₹ 9.49 per equity share
- 6
New projects including Di Methyl Ether (DME), N-Methyl Morpholine (NMM), and Acetonitrile (ACN) are under execution and expected to be commissioned by FY 2026-27
- 7
New expansion of Rs. 750 crs in Subsidiary Balaji Speciality Chemicals Limited is underway with Mega Project status granted by the Government of Maharashtra
Management Comments
Mr. D. Ram Reddy
Managing Director
For the quarter and period ended 31st December 2025, business activity continued to be relatively stable primarily on account of softer demand trends in the pharmaceutical and agrochemical segments, impacted by ongoing global uncertainties. Nevertheless, with key projects advancing on schedule, the company expects a steady pickup in performance in the upcoming quarters as additional capacities are expected to contribute to the top and bottom line.
Informational and educational content only. Not investment advice.